lactic acid has been researched along with Bile Duct Cancer in 8 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to fabricate a vorinostat (Zolinza™)-eluting nanofiber membrane-coated gastrointestinal (GI) stent and to study its antitumor activity against cholangiocarcinoma (CCA) cells in vitro and in vivo." | 7.85 | Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells. ( Jeong, YI; Kang, DH; Kim, C; Kim, J; Kwak, TW; Lee, HL; Seo, SJ; Song, YH, 2017) |
| "The aim of this study was to fabricate a vorinostat (Zolinza™)-eluting nanofiber membrane-coated gastrointestinal (GI) stent and to study its antitumor activity against cholangiocarcinoma (CCA) cells in vitro and in vivo." | 3.85 | Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells. ( Jeong, YI; Kang, DH; Kim, C; Kim, J; Kwak, TW; Lee, HL; Seo, SJ; Song, YH, 2017) |
| "Cholangiocarcinoma (CCA), or cancer of bile duct epithelial cells, is a very aggressive malignancy characterized by early lymphangiogenesis in the tumor microenvironment (TME) and lymph node (LN) metastasis which correlate with adverse patient outcome." | 1.62 | Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma. ( Alpini, G; Banerjee, P; Bayless, KJ; Chakraborty, S; Chauhan, R; Ekser, B; Glaser, SS; Kumaravel, S; O'Brien, A; Roy, S; Seelig, C; White, TK, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Roy, S | 1 |
| Kumaravel, S | 1 |
| Banerjee, P | 1 |
| White, TK | 1 |
| O'Brien, A | 1 |
| Seelig, C | 1 |
| Chauhan, R | 1 |
| Ekser, B | 1 |
| Bayless, KJ | 1 |
| Alpini, G | 1 |
| Glaser, SS | 1 |
| Chakraborty, S | 1 |
| Sun, J | 1 |
| Feng, M | 1 |
| Zou, H | 1 |
| Mao, Y | 1 |
| Yu, W | 1 |
| Piasentin, N | 1 |
| Milotti, E | 1 |
| Chignola, R | 1 |
| Yokoyama, Y | 1 |
| Mizuno, T | 1 |
| Sugawara, G | 1 |
| Asahara, T | 1 |
| Nomoto, K | 1 |
| Igami, T | 1 |
| Ebata, T | 1 |
| Nagino, M | 1 |
| Kwak, TW | 1 |
| Lee, HL | 1 |
| Song, YH | 1 |
| Kim, C | 1 |
| Kim, J | 1 |
| Seo, SJ | 1 |
| Jeong, YI | 1 |
| Kang, DH | 1 |
| Bahitham, W | 1 |
| Liao, X | 1 |
| Peng, F | 1 |
| Bamforth, F | 1 |
| Chan, A | 1 |
| Mason, A | 1 |
| Stone, B | 1 |
| Stothard, P | 1 |
| Sergi, C | 1 |
| Li, M | 1 |
| Lu, W | 1 |
| Zhang, F | 1 |
| Ding, Q | 1 |
| Wu, X | 1 |
| Tan, Z | 1 |
| Wu, W | 1 |
| Weng, H | 1 |
| Wang, X | 1 |
| Shi, W | 1 |
| Dong, P | 1 |
| Gu, J | 1 |
| Liu, Y | 1 |
| Nishijima, T | 1 |
| Nishina, M | 1 |
| Fujiwara, K | 1 |
8 other studies available for lactic acid and Bile Duct Cancer
| Article | Year |
|---|---|
Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma.
Topics: Animals; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Chemokine CXCL5; Cholangiocarcinoma; | 2021 |
Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cholan | 2023 |
The control of acidity in tumor cells: a biophysical model.
Topics: Antigens, Neoplasm; Bile Duct Neoplasms; Carbon Dioxide; Carbonic Anhydrase IX; Cell Hypoxia; Cell L | 2020 |
Profile of preoperative fecal organic acids closely predicts the incidence of postoperative infectious complications after major hepatectomy with extrahepatic bile duct resection: Importance of fecal acetic acid plus butyric acid minus lactic acid gap.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Butyric | 2017 |
Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells.
Topics: Animals; Antineoplastic Agents; Bile Duct Neoplasms; Cell Line, Tumor; Cholangiocarcinoma; Drug Deli | 2017 |
Mitochondriome and cholangiocellular carcinoma.
Topics: Amino Acid Substitution; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangioc | 2014 |
[Anti-tumor effects of DDP-PLLA-CNTs on human cholangiocarcinoma cell line in vitro].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cholangiocarcin | 2014 |
Measurement of lactate levels in serum and bile using proton nuclear magnetic resonance in patients with hepatobiliary diseases: its utility in detection of malignancies.
Topics: Adult; Aged; alpha-Fetoproteins; Bile; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers; Bi | 1997 |